@CognitionStudio

Strategic Visual Communication for Life Science and Health Care. Science storytelling. Brand communications. Digital solutions.

 SEATTLE
cognitionstudio.com
Joined March 2009
  • Tweets3.4K
  • Following787
  • Followers654
56Media
We have updated our COVID-19 case study with a downloadable poster presenting information about the SARS-CoV-2 RNA-dependent RNA Polymerase (RdRp) and Remdesivir Mechanism of Action. cognitionstudio.com/covid-19… #Covid_19
2
1
3
This MOA #animation by @cognitionstudio was one of four videos displayed on the side of a 13-foot, 30,000-pound cube exhibited at the 2023 European Hematological Association's (EHA) conference in Frankfurt, Germany. Explore more: buff.ly/3jWziqG #mechanismofaction #3D
1
5
288
This #animation by @cognitionstudio was one of four videos displayed on the side of a 13-foot, 30,000-pound Cube exhibited at the 2023 European Hematological Association's (EHA) conference Germany. Explore more: buff.ly/3jWziqG #hematology #biotech #medicalanimation
2
1
3
459
A hacker leaked millions of 23andMe users' data, putting sensitive health information in jeopardy - endpts.com/a-hacker-leaked-m…

A hacker leaked millions of 23andMe users’ data, and the leak of ancestry data could have implica...

(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) Consumer genetics testing giant 23andMe is experiencing a major data leak. ...

endpoints.news
77
Flagship poaches another pharma R&D leader as GSK's Lepore heads to ProFound - endpts.com/flagship-poaches-…

Flagship poaches another pharma R&D leader as GSK's Lepore heads to ProFound

John Lepore, the former right-hand man for Hal Barron and Tony Wood at GSK, is departing the UK pharma giant to lead a Flagship Pioneering startup, joining the growing ...

endpoints.news
51
GLP-1 drugs are transforming diabetes, obesity and more. Could a Nobel be next? statnews.com/2023/09/30/weig… via @statnews

GLP-1 drugs are transforming diabetes, obesity and more. Could a Nobel be next?

If the discoveries that gave us Ozempic and Mounjaro find their way to the Nobel spotlight, who would win? Here’s the story of which scientists did what.

statnews.com
63
Regeneron brings its antibody chops to gene editing's biggest problem - endpts.com/regeneron-brings-…

In the Lab: Regeneron brings its antibody chops to gene editing's biggest problem, aiming to...

TARRYTOWN, NY — For over three decades, Regeneron has been synonymous with one thing in the drug industry: antibodies. Blockbusters like Dupixent, Eylea, and Covid-19 antibodies have transformed what...

endpoints.news
51
This needs to change. A popular breast cancer genomic test underestimates risks for Black women statnews.com/2023/09/19/estr… via @statnews

A popular breast cancer genomic test underestimates risks for Black women

Racial disparities are a bitter reality of many aspects of cancer care, but these discrepancies are most acute in breast cancer.

statnews.com
43
Recast Capital, with backing from Melinda Gates, commits $3.6 million to support women- and nonbinary-led VC firms bizjournals.com/bizwomen/new…

Recast Capital, with backing from Melinda Gates, commits $3.6 million to support women- and...

The funds will be used to support other VC funds led by women and nonbinary individuals.

bizjournals.com
45
Neumora boards IPO train as second PhIII biotech to file Nasdaq plans this week - endpts.com/neumora-boards-ip…

Neumora's big neuroscience plans head toward the Nasdaq in second PhIII biotech IPO pitch in 24...

The largely dormant biotech IPO market started sizzling Friday, with two Phase III drug developers sending in their pitches for Nasdaq debuts this fall. After Friday’s closing bell, the ...

endpoints.news
84
Medical illustrations neglect people with dark skin. A Nigerian doctor-to-be is working to change that statnews.com/2023/08/22/dive… via @statnews

Medical illustrations neglect people with dark skin. A Nigerian doctor-to-be is working to change...

A 2018 study found that only 4.5% of the images in medical textbooks feature darker skin tones.

statnews.com
62
Gilead tracks HIV grant giving in hard-hit US South over past five years - endpts.com/gilead-tracks-hiv…

Gilead tracks five years of HIV grant giving in hard-hit US South, and doubles down on new approa...

Gilead Sciences is now halfway through its 10-year pledge in the US southern states to tackle HIV through community grants, and looking back while also doubling down on new approaches ...

endpoints.news
47
Regeneron to buy gene therapy biotech Decibel Therapeutics in small $109M deal - endpts.com/regeneron-to-buy-…

Regeneron to buy gene therapy biotech Decibel Therapeutics in small $109M deal

Regeneron is buying Decibel Therapeutics and its hearing loss gene therapies for a modest $109 million, the companies announced Wednesday morning. Regeneron and Decibel have been ...

endpoints.news
45
Community health workers, experts in the in-between, fight for their place in the system statnews.com/2023/08/07/comm… via @statnews

Community health workers, experts in the in-between, fight for their place in the system

"Having that kind of expertise on what it really means to walk in that person's shoes, and to empathize on that level — I think that is a lot of what's missing sometimes in our clinical care.”

statnews.com
40
Congrats @NeumoraTx readies three PhIII trials for depression drug under new CEO - endpts.com/neumora-readies-t…

Neumora goes big with three PhIII depression studies, new CEO from AbbVie’s C-suite

The wheels are rolling fast at Neumora as the “Really Big Neuroscience Company” nears three Phase III trials for its investigational depression drug, readies a slate of other clinical ...

endpoints.news
51
China approves first BCMA CAR-T therapy from Innovent, IASO Bio - endpts.com/china-approves-fi…

China approves BCMA CAR-T therapy for multiple myeloma, with Innovent beating Legend in race to be...

Innovent and IASO Bio received the first approval in China for a CAR-T therapy for multiple myeloma. The therapy, known as equecabtagene autoleucel, will be marketed as Fucaso, Innovent announced ...

endpoints.news
50
How a six-in-one vaccine could soon help the world get rid of polio for good statnews.com/2023/06/23/poli… via @statnews

How a six-in-one vaccine could soon help the world get rid of polio for good

A new vaccine could increase the number of children around the world who are protected against the worst of what polioviruses can do.

statnews.com
34
Scientists successfully unfroze rat organs and transplanted them — a ‘historic’ step that could someday transform transplant medicine statnews.com/2023/06/21/cryo… via @statnews

Scientists successfully unfroze rat organs and transplanted them — a ‘historic’ step that could...

In an ‘historic’ first, scientists freeze, thaw, and transplant rat organs — bringing transplant medicine one step closer to sci-fi dreams of stopping biological time.

statnews.com
24
Congratulations! Limeade to be bought by WebMD Health Services for $75M bizjournals.com/seattle/news… via @PSBJ

Limeade to be bought by WebMD Health Services for $75M

The companies expect the $75.3 million deal to close in the next quarter.

bizjournals.com
34
Increasing Access to Care and Efficiency in Healthcare Delivery in Low- and Middle-Income Countries globalforum.diaglobal.org/is…

Increasing Access to Care and Efficiency in Healthcare Delivery in Low- and Middle-Income Countries

Socioeconomic inequalities in medical care access and affordability, large out-of-pocket expenses, and vulnerabilities against catastrophic household expenditures continue to be significant barriers...

globalforum.diaglobal.org
26
I wanted to personally share and congratulate Eleanor Lewis, grade 12, on winning the 2023 National High School Design Competition. Plant Resilient Project was an ambitious use of data to drive community impact, check it out. lnkd.in/gcxW6m3c . #HSDesignCompetition

LinkedIn

This link will take you to a page that’s not on LinkedIn

lnkd.in
36
Load more